The 47-year-old comedian - who lost his sight when he was 22 due to hereditary condition Retinitis Pigmentosa - became the ...

Fintel reports that on February 12, 2025, Jones Trading initiated coverage of ProQR Therapeutics N.V. (NasdaqCM:PRQR) with a ...

Resilient couple overcomes health challenges to build successful Neyyappam business, symbolizing hope and perseverance in Kerala.

Shares of Kala Bio Inc. tumbled over 35% on Wednesday, on track for their worst single-day decline ever, after the company ...

Mr. Iwicki stated, “I am proud of the work we have done at KALA utilizing our MSC-S platform, and I am very excited about the potential of our lead product candidate, KPI-012 for the treatment of PCED ...

KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative ...

Patients who received a single injection of Lumevoq displayed sustained clinical recovery in a rare condition that can lead ...

Ocugen (OCGN) announced that dosing is complete, ahead of schedule in the Phase 2 portion of the Phase 1/2 ArMaDa clinical trial for OCU410-a ...

The Foundation Fighting Blindness, the driving force in the global development of treatments and cures for blinding diseases, recognizes 20 years of its VisionWalk fundraising program in 2025. This ...